Skip to main navigation
Skip to search
Skip to main content
Universidad de los Andes Home
English
Español
Search content at Universidad de los Andes
Home
Profiles
Research units
Research output
Projects
Press/Media
Activities
Equipment
Student theses
Prizes
Courses
Impacts
RNAi therapeutics: Current status of nanoncologic siRNA delivery systems
Y. N. Cho
, J. S. Brumbach
, Murugan Ramalingam
, Z. S. Haidar
Research output
:
Contribution to journal
›
Scientific review
›
peer-review
4
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'RNAi therapeutics: Current status of nanoncologic siRNA delivery systems'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
RNA Interference
100%
Small Interfering RNA (siRNA)
100%
Small Interfering RNA (siRNA) Delivery
100%
SiRNA Delivery System
100%
Clinical Efficacy
25%
Delivery System
25%
Antisense Gene
25%
Ongoing Clinical Trials
25%
Inhibit Tumor
25%
Off-target Effects
25%
Cancer Therapy
25%
Cancer Treatment
25%
Tumor Cell Proliferation
25%
Drug Carrier
25%
Adverse Effects
25%
Gene Silencing
25%
Tumor Growth
25%
Immunogenicity
25%
Nuclease
25%
Therapeutic Agents
25%
Target Specificity
25%
Metastasis
25%
Anticancer Drugs
25%
Cellular Uptake
25%
Pharmacology, Toxicology and Pharmaceutical Science
Small Interfering RNA
100%
Malignant Neoplasm
42%
Disease
28%
Neoplasm
14%
Clinical Trial
14%
Adverse Event
14%
Anticarcinogen
14%
Nuclease
14%
Immunogenicity
14%
Tumor Growth
14%